Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12216)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2014 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kyuno D, Yamaguchi H, Ito T, Kono T, Kimura Y, Imamura M, Konno T, Hirata K, Sawada N, Kojima T. Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer. World J Gastroenterol 2014; 20(31): 10813-10824 [PMID: 25152584 DOI: 10.3748/wjg.v20.i31.10813] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i31/10813.htm |
| Number | Citing Articles |
| 1 |
Bogdan Silviu Ungureanu, Cristian-Virgil Lungulescu, Daniel Pirici, Adina Turcu-Stiolica, Dan Ionut Gheonea, Victor Mihai Sacerdotianu, Ilona Mihaela Liliac, Emil Moraru, Felix Bende, Adrian Saftoiu. Clinicopathologic Relevance of Claudin 18.2 Expression in Gastric Cancer: A Meta-Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.643872
|
| 2 |
Wanqiong Yuan, Ting Li, Xiaoning Mo, Xiaolin Wang, Baocai Liu, Wenyan Wang, Yu Su, Lan Xu, Wenling Han. Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway. Oncotarget 2016; 7(20): 29507 doi: 10.18632/oncotarget.8789
|
| 3 |
S. M. Nasir Uddin, Asfia Sultana, Asma Fatima, Anupriya M. Geethakumari, Kabir H. Biswas. Tight Junctions in Inflammation and Cancer. 2023; : 49 doi: 10.1007/978-981-99-2415-8_2
|
| 4 |
Yosuke Hashimoto, Kiyohito Yagi, Masuo Kondoh. Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers. Pflügers Archiv - European Journal of Physiology 2017; 469(1): 45 doi: 10.1007/s00424-016-1878-6
|
| 5 |
Nanami Nakamura, Hisako Fujihara, Koji Kawaguchi, Hiroyuki Yamada, Ryoko Nakayama, Masaaki Yasukawa, Yuta Kishi, Yoshiki Hamada, Mitsuko Masutani. Possible Action of Olaparib for Preventing Invasion of Oral Squamous Cell Carcinoma In Vitro and In Vivo. International Journal of Molecular Sciences 2022; 23(5): 2527 doi: 10.3390/ijms23052527
|
| 6 |
Ewa Tomaszewska, Małgorzata Świątkiewicz, Siemowit Muszyński, Janine Donaldson, Katarzyna Ropka-Molik, Marcin B. Arciszewski, Maciej Murawski, Tomasz Schwarz, Piotr Dobrowolski, Sylwia Szymańczyk, Sławomir Dresler, Joanna Bonior. Repetitive Cerulein-Induced Chronic Pancreatitis in Growing Pigs—A Pilot Study. International Journal of Molecular Sciences 2023; 24(9): 7715 doi: 10.3390/ijms24097715
|
| 7 |
Xiaowei Zhang, Haiming Wang, Qian Li, Yunpeng Liu, Peiqing Zhao, Tao Li. RETRACTED ARTICLE: Differences in the expression profiles of claudin proteins in human nasopharyngeal carcinoma compared with non-neoplastic mucosa. Diagnostic Pathology 2018; 13(1) doi: 10.1186/s13000-018-0685-0
|
| 8 |
Weiyun Wu, Wenkai Tan, Shicai Ye, Yu Zhou, Juanhua Quan. Analysis of the promoter region of the human miR‑32 gene in colorectal cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10042
|
| 9 |
Rina Fujiwara-Tani, Shiori Mori, Ruiko Ogata, Rika Sasaki, Ayaka Ikemoto, Shingo Kishi, Masuo Kondoh, Hiroki Kuniyasu. Claudin-4: A New Molecular Target for Epithelial Cancer Therapy. International Journal of Molecular Sciences 2023; 24(6): 5494 doi: 10.3390/ijms24065494
|
| 10 |
Caroline Hana, Nyein Nyein Thaw Dar, Michael Galo Venegas, Michel Vulfovich. Claudins in Cancer: A Current and Future Therapeutic Target. International Journal of Molecular Sciences 2024; 25(9): 4634 doi: 10.3390/ijms25094634
|
| 11 |
De-Wen Wang, Wei-Han Zhang, Galiullin Danil, Kun Yang, Jian-Kun Hu. The role and mechanism of claudins in cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1051497
|
| 12 |
Tao Fan, Liang Xue, Bingzheng Dong, Houguang He, Wenda Zhang, Lin Hao, Weiming Ma, Guanghui Zang, Conghui Han, Yang Dong. CDH1 overexpression predicts bladder cancer from early stage and inversely correlates with immune infiltration. BMC Urology 2022; 22(1) doi: 10.1186/s12894-022-01103-7
|
| 13 |
Manoj Kumar, Rishi Kumar Jaiswal, Pramod K. Yadava, Rana P. Singh. An assessment of poly (ADP‐ribose) polymerase‐1 role in normal and cancer cells. BioFactors 2020; 46(6): 894 doi: 10.1002/biof.1688
|
| 14 |
Qianman Peng, Dan Shan, Kui Cui, Kathryn Li, Bo Zhu, Hao Wu, Beibei Wang, Scott Wong, Vikram Norton, Yunzhou Dong, Yao Wei Lu, Changcheng Zhou, Hong Chen. The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease. Cells 2022; 11(11): 1834 doi: 10.3390/cells11111834
|
| 15 |
Feiyang Deng, Hua Zhang, Xing Wang, Yuan Zhang, Hongxiang Hu, Siyang Song, Wenbing Dai, Bing He, Ying Zheng, Xueqing Wang, Qiang Zhang. Transmembrane Pathways and Mechanisms of Rod-like Paclitaxel Nanocrystals through MDCK Polarized Monolayer. ACS Applied Materials & Interfaces 2017; 9(7): 5803 doi: 10.1021/acsami.6b15151
|
| 16 |
Risa Akizuki, Hiroaki Eguchi, Satoshi Endo, Toshiyuki Matsunaga, Akira Ikari. ZO-2 Suppresses Cell Migration Mediated by a Reduction in Matrix Metalloproteinase 2 in Claudin-18-Expressing Lung Adenocarcinoma A549 Cells. Biological and Pharmaceutical Bulletin 2019; 42(2): 247 doi: 10.1248/bpb.b18-00670
|
| 17 |
Sergei V. Boichuk, Firyuza F. Bikinieva, Pavel B. Kopnin. The claudin family of proteins in the pathogenesis and treatment of malignancies: current insights and future prospects. Russian Journal of Oncology 2024; 29(3): 258 doi: 10.17816/onco636917
|
| 18 |
Zhen Liu, Zhipan Hong, Hui Ma, Dake Yu, Pengpeng Qu. Key factors mediated by PI3K signaling pathway and related genes in endometrial carcinoma. Journal of Bioenergetics and Biomembranes 2020; 52(6): 465 doi: 10.1007/s10863-020-09854-4
|
| 19 |
MEHMET KARABULUT, HALIL ALIS, KORAY BAS, SENEM KARABULUT, CIGDEM USUL AFSAR, HILAL OGUZ, MERAL GUNALDI, CEVHER AKARSU, OSMAN KONES, NURI FARUK AYKAN. Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer. Molecular and Clinical Oncology 2015; 3(6): 1255 doi: 10.3892/mco.2015.626
|
| 20 |
Sylwia Bartoszewska, Jakub Sławski, James F. Collawn, Rafal Bartoszewski. HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies. Cancers 2023; 15(11): 2903 doi: 10.3390/cancers15112903
|
| 21 |
Liuyun Gong, Dan Zhang, Yutiantian Lei, Yuanjie Qian, Xinyue Tan, Suxia Han. Transcriptome‐wide association study identifies multiple genes and pathways associated with pancreatic cancer. Cancer Medicine 2018; 7(11): 5727 doi: 10.1002/cam4.1836
|
| 22 |
Delphine Demeestere, Claude Libert, Roosmarijn E. Vandenbroucke. Clinical implications of leukocyte infiltration at the choroid plexus in (neuro)inflammatory disorders. Drug Discovery Today 2015; 20(8): 928 doi: 10.1016/j.drudis.2015.05.003
|
| 23 |
Makoto Osanai, Akira Takasawa, Masaki Murata, Norimasa Sawada. Claudins in cancer: bench to bedside. Pflügers Archiv - European Journal of Physiology 2017; 469(1): 55 doi: 10.1007/s00424-016-1877-7
|
| 24 |
Shirong Li, Saiping Qi, Yanmeng Li, Chunpan Zhang, Lan Sun, Chunquan Liu, Haoyan Wang. MARVELD3 inhibits the epithelial‐mesenchymal transition and cell migration by suppressing the Wnt/β‐catenin signaling pathway in non–small cell lung cancer cells. Thoracic Cancer 2023; 14(12): 1045 doi: 10.1111/1759-7714.14844
|
| 25 |
Trevor R. Leonardo, Junhe Shi, Dandan Chen, Harsh M. Trivedi, Lin Chen. Differential Expression and Function of Bicellular Tight Junctions in Skin and Oral Wound Healing. International Journal of Molecular Sciences 2020; 21(8): 2966 doi: 10.3390/ijms21082966
|
| 26 |
Joseph L. Mertz, Srinivasa R. Sripathi, Xue Yang, Lijun Chen, Noriko Esumi, Hui Zhang, Donald J. Zack. Proteomic and phosphoproteomic analyses identify liver-related signaling in retinal pigment epithelial cells during EMT. Cell Reports 2021; 37(3): 109866 doi: 10.1016/j.celrep.2021.109866
|
| 27 |
Fangqian Du, Yuwei Xie, Shengze Wu, Mengling Ji, Bingzi Dong, Chengzhan Zhu. Expression and Targeted Application of Claudins Family in Hepatobiliary and Pancreatic Diseases. Journal of Hepatocellular Carcinoma 2024; : 1801 doi: 10.2147/JHC.S483861
|
| 28 |
Zhi-Peng You, Shan-Shan Chen, Zhong-Yi Yang, Shu-Rong Li, Fan Xiong, Ting Liu, Shu-Hua Fu. GEP100/ARF6 regulates VEGFR2 signaling to facilitate high-glucose-induced epithelial-mesenchymal transition and cell permeability in retinal pigment epithelial cells. American Journal of Physiology-Cell Physiology 2019; 316(6): C782 doi: 10.1152/ajpcell.00312.2018
|
| 29 |
Byung Woog Kang, Ian Chau. Emerging agents for metastatic pancreatic cancer: spotlight on early phase clinical trials. Expert Opinion on Investigational Drugs 2021; 30(11): 1089 doi: 10.1080/13543784.2021.1995354
|
| 30 |
Kalyani Patil, Farheen B. Khan, Sabah Akhtar, Aamir Ahmad, Shahab Uddin. The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance. Cancer and Metastasis Reviews 2021; 40(3): 691 doi: 10.1007/s10555-021-09979-x
|
| 31 |
Qiushi Xu, Bing Yu, Wenjing Chen, Wenlong Li, Yuanhao Sun, Yanchun Fang. CircSERPINA3 promoted cell proliferation, migration, and invasion of laryngeal squamous cell carcinoma by targeting miR‐885‐5p. Cell Biology International 2022; 46(11): 1852 doi: 10.1002/cbin.11872
|
| 32 |
Clark A. Jones, Lori A. Hazlehurst. Role of Calcium Homeostasis in Modulating EMT in Cancer. Biomedicines 2021; 9(9): 1200 doi: 10.3390/biomedicines9091200
|
| 33 |
Daoyu Tao, Bingxin Guan, Hui Li, Chengjun Zhou. Expression patterns of claudins in cancer. Heliyon 2023; 9(11): e21338 doi: 10.1016/j.heliyon.2023.e21338
|
| 34 |
James H. Monkman, Erik W. Thompson, Shivashankar H. Nagaraj. Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease. Cancers 2019; 11(11): 1745 doi: 10.3390/cancers11111745
|
| 35 |
Fumisato Maesaka, Masaomi Kuwada, Shohei Horii, Shingo Kishi, Rina Fujiwara-Tani, Shiori Mori, Kiyomu Fujii, Takuya Mori, Hitoshi Ohmori, Takuya Owari, Makito Miyake, Yasushi Nakai, Nobumichi Tanaka, Ujjal Kumar Bhawal, Yi Luo, Masuo Kondoh, Kiyohide Fujimoto, Hiroki Kuniyasu. Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer. International Journal of Molecular Sciences 2022; 23(12): 6516 doi: 10.3390/ijms23126516
|
| 36 |
MENGYAO JI, DIKUN FAN, LEI YUAN, YUNTING ZHANG, WEIGUO DONG, XIULAN PENG. EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β-catenin/E-cadherin pathway. Experimental and Therapeutic Medicine 2015; 10(4): 1311 doi: 10.3892/etm.2015.2684
|
| 37 |
Lisa-Marie Philipp, Umut-Ulas Yesilyurt, Arne Surrow, Axel Künstner, Anne-Sophie Mehdorn, Charlotte Hauser, Jan-Paul Gundlach, Olga Will, Patrick Hoffmann, Lea Stahmer, Sören Franzenburg, Hendrike Knaack, Udo Schumacher, Hauke Busch, Susanne Sebens. Epithelial and Mesenchymal-like Pancreatic Cancer Cells Exhibit Different Stem Cell Phenotypes Associated with Different Metastatic Propensities. Cancers 2024; 16(4): 686 doi: 10.3390/cancers16040686
|